Pemphigus in India

Indian Journal of Dermatology, Venereology and Leprology

Volumn 77, Issue 4, 2011, Pages 439-449

  Kanwar, Amrinder J ^a   De, Dipankar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

clinical features; diagnosis; India; management; Pemphigus

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE DEXAMETHASONE PULSE; DAPSONE; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; DEXAMETHASONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALOPECIA; ANAPHYLAXIS; ARTERY THROMBOSIS; ARTHRALGIA; AUTOIMMUNE DISEASE; BLURRED VISION; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CUSHING DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG MEGADOSE; DYSGEUSIA; DYSPNEA; ECCHYMOSIS; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HEADACHE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HICCUP; HIRSUTISM; HUMAN; HYPOPYON; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INCREASED APPETITE; INDIA; MACULOPAPULAR RASH; MENSTRUATION DISORDER; MORTALITY; NAIL DISEASE; ORAL MUCOSAL DISEASE; OSTEOPOROSIS; PAIN; PARESTHESIA; PATHOGENESIS; PEMPHIGUS; PEMPHIGUS VEGETAN; PEMPHIGUS VULGARIS; PEPTIC ULCER; PERIPHERAL EDEMA; POLYURIA; POSTPEMPHIGUS ACANTHOMATA; PREGNANCY; PREGNANCY OUTCOME; PSYCHOSIS; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SHIVERING; SIDE EFFECT; SLEEP DISORDER; SQUAMOUS CELL; WEAKNESS;

ADRENAL CORTEX HORMONES; ANIMALS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; HUMANS; INDIA; PEMPHIGUS;

EID: 79960280712     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.82396     Document Type: Conference Paper

References (89)

1. Grando SA. Pemphigus in 21st century. New life to an old story. Autoimmunity 2006;39:521-30. (Pubitemid 46401640)
2. Scmidt E, Waschke J. Apoptosis in pemphigus. Autoimmun Rev 2009;8:533-7.
3. Desai S, Rao S. Pemphigus in India: Report of 21 cases. Hautarzt 1960;11:445-53.
4. Mascarenhas MF, Hede RV, Shukla P, Nadkarni NS, Rege VL. Pemphigus in Goa. J Indian Med Assoc 1994;92:342-3.
5. Kanwar AJ, Ajith C, Narang T. Pemphigus in North India. J Cutan Med Surg 2006;10:21-5. (Pubitemid 351506625)
6. Ajithkumar K. Incidence of pemphigus in Thrissur district, South India. Indian J Dermatol Venereol Leprol 2008;74:349-51.
7. Sehgal VN. Pemphigus in India: A note. Indian J Dermatol 1972;18:5-7.
8. Kandhari KC, Pasricha JS. Pemphigus in Northern India-clinical studies in 34 patients. Indian J Dermatol Venereol Leprol 1965;31:62.
9. Ambady BM, Sugathan P, Nair BK. Pemphigus. Indian J Dermatol Venereol Leprol 1965;31:239.
10. Sehgal VN. Pemphigus-A reappraisal of clinical and histological features in Indian patients. Dermatologica 1969;139:381-9.
11. Fernandez JC, Dharani JB, Desai SC. A study of 100 cases of pemphigus-clinical features. Indian J Dermatol Venereol Leprol 1970;36:1-9.
12. Singh RP. Pemphigus in tropics. Indian J Dermatol 1970;15:69-73.
13. Wilson CL, Wojnarowska F, Dean D, Pasricha JS. IgG subclasses in pemphigus in Indian and UK populations. Clin Exp Dermatol 1993;18:226-30. (Pubitemid 23171140)
14. Aboobaker J, Morar N, Ramdial PK, Hammond MG. Pemphigus in South Africa. Int J Dermatol 2001;40:115-9. (Pubitemid 32396558)
15. Singh R, Pandhi RK, Pal D, Kalla G. A clinicopathological study of pemphigus. Indian J Dermatol Venereol Leprol 1973;39:126-32.
16. Meyer N, Misery L. Geo-epidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 2010;9:A379-82.
17. Kanwar AJ, Kaur S. Pemphigus in children. Int J Dermatol 1991;30:343-6.
18. Kanwar AJ, Dhar S, Kaur S. Further experience with pemphigus in children. Pediatr Dermatol 1994;11:107-11. (Pubitemid 24174275)
19. Handa F, Aggarwal RR, Kumar R. A clinical study of 85 cases of pemphigus. Indian J Dermatol Venereol Leprol 1973;39:106-11.
20. Capon F, Bharkhada J, Cochrane NE, Mortimer NJ, Setterfield JF, Reynaert S, et al. Evidence of association between desmoglein 3 haplotypes and pemphigus vulgaris. Br J Dermatol 2006;154:67-71. (Pubitemid 43381322)
21. Delgado JC, Yunis DE, Bozon MV, Salazar M, Deulofeut R, Turbay D, et al. MHC class 2 alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue Antigens 1996;48:668-72. (Pubitemid 27019691)
22. Kumar B, Arora S, Kumaran MS, Jain R, Dogra S. Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus. Indian J Dermatol Venereol Leprol 2006;72:203-6. (Pubitemid 43893188)
23. Sharma VK, Prasad HR, Khandpur S, Kumar A. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris. Int J Dermatol 2006;45:518-22.
24. Satyam A, Khandpur S, Sharma VK, Sharma A. Involvement of Th1/Th2 cytokines in the pathogenesis of autoimmune skin disease-pemphigus vulgaris. Immunol Invest 2009;38:498-509.
25. Kanwar AJ, Thami GP, Bedi GK. IgG subclasses in pemphigus vulgaris. Indian J Dermatol Venereol Leprol 1997;63:20-1. (Pubitemid 128011318)
26. Shamim T, Verghese VI, Shameena PM, Sudha S. pemphigus vulgaris in oral cavity: Clinical evaluation of 71 cases. Med Oral Patol Oral Cir Bucal 2008;13:E622-6.
27. Sawant P, Starkar RP, Chopda N, Amladi ST, Nanivadekar SA, Deodhar KP. Esophageal involvement in pemphigus vulgaris. Indian J Gastroenterol 1994;13:133-4.
28. Narasimha RP, Samarth A, Aurangbadkar SJ, Partap B, Lashmi TS. Study of upper gastrointestinal tract involvement in pemphigus. Indian J Dermatol Venereol Leprol 2006;72:421-4.
29. Trattner A, Lurie R, Leiser A, David M, Hazaz B, Kadish U, et al. Esophageal involvement in pemphigus vulgaris: A clinical, histologic and immunopathologic study. J Am Acad Dermatol 1991;24:2236.
30. Bhargava P, Kuldeep CM, Mathur NK. Isolated pemphigus vegetans of the tongue. Indian J Dermatol Venereol Leprol 2001;67:267.
31. Sehgal VN, Sharma S, Sardana K. Unilateral refractory (erosive) conjunctivitis: A peculiar manifestation of pemphigus vulgaris. Skinmed 2005;4:250-2.
32. Gupta S, Sodhani P, Jain S. Acantholytic cells exfoliated from pemphigus vulgaris of the uterine cervix. A case report. Acta Cytol 2003;47:795-8. (Pubitemid 37128609)
33. Gharami RC, Kumar P, Mondal A, Ghosh K. Dyshydrosiform pemphigus vulgaris: Report of an unusual case. Dermatol Online J 2010;16:10.
34. Premlatha S, Jayakumar S, Yesudian P, Thambiah AS. Cerebriform tongue-A clinical sign of pemphigus vegetans. Br J Dermatol 1981;104:587-91. (Pubitemid 12192119)
35. Singh S, Gupta S, Chaudhary R. Hypopyon sign in pemphigus vulgaris and pemphigus foliaceous. Int J Dermatol 2009;48:1100-2.
36. Yesudian PV, Krishnan SG, Jayaraman M, Janaki VR, Yesudian P. Postpemphigus acanthomata: A sign of clinical activity? Int J Dermatol 1997;36:194-6. (Pubitemid 27208313)
37. Kanwar AJ, Ghosh S, Dhar S, Kaur S. Odor in pemphigus. Dermatology 1992;185:215.
38. Kanwar AJ, Gupta R, Kaur S. Pruritus-A clinical sign of activity of pemphigus. Indian J Dermatol Venereol Leprol 1989;55:396. (Pubitemid 20126826)
39. Mehta V, Balachandran C, Nayak S. Herpetiform pemphigus clinically resembling bullous pemphigoid. Indian J Dermatol 2008;53:158-9.
40. Ray R, Kanwar AJ, Ravichandran P, Ghosh S, Dhar S, Sarode R, et al. Pemphigus vulgaris with cryoglobulinemia and cold agglutinin disease. J Assoc Physicians India 1994;42:420-2.
41. Kanwar AJ, Dawn G, Dhar S, Gangopadhyay M. Pemphigus vulgaris and renal cell carcinoma. Int J Dermatol 1996;35:723-4. (Pubitemid 26356121)
42. Khandpur S, Reddy BS. An unusual association of pemphigus vulgaris with hyperprolactinemia. Int J Dermatol 2002;41:696-9. (Pubitemid 35252051)
43. Awasthy N, Chand K, Singh A. Brain abscesses with pemphigus vulgaris-A rare association. Dermatol Online J 2005;11:35.
44. Shaerer L, Trueb RM. Direct immunofluorescence of plucked hair. Arch Dermatol 2003;139:228-9.
45. Rao R, Dasari K, Shenoi S, Balachandran C. Demonstration of pemphigus-specific immunofluorescence pattern by direct immunofluorescence of plucked hair. Int J Dermatol 2009;48:1187-9.
46. Wilson CL, Dean D, Wojnorwoska F. Pemphigus and the terminal hair follicle. J Cutan Pathol 1991;18:428-31.
47. Aithal V, Kini U, Jayaseelan E. Role of direct immunofluorescence on Tzanck smears in pemphigus vulgaris. Diagn Cytopathol 2007;35:403-7. (Pubitemid 47021011)
48. Verma KK, Khaitan BK, Singh MK. Antibody deposits in Tzanck smears in pemphigus vulgaris. J Cutan Pathol 1993;20:317-9. (Pubitemid 23249609)
49. Sethi JK, Kanwar AJ, Kaur S, Sehgal S. Direct immunofluorescence as a diagnostic and prognostic marker in pemphigus. Indian J Dermatol Venereol Leprol 1992;58:379-83. (Pubitemid 23183862)
50. Kumar S, Thappa DM, Sehgal S. Immunofluorescence study of pemphigus from north India. J Dermatol 1995;22:571-5.
51. Shanmugasekar C, Ram Ganesh VR, Jayaraman A, Srinivas CR. Blister fluid immunofluorescence in a case of pemphigus vulgaris. Indian J Dermatol 2010;55:188-9.
52. Lever WF, White H. Treatment of pemphigus with corticosteroids: Results obtained in 46 patients over a period of 11 years. Arch Dermatol 1963;87:12-26.
53. Pasricha JS, Gupta R. Pulse therapy with dexamethasone-cyclophosphamide in pemphigus. Indian J Dermatol Venereol Leprol 1984;50:199-203.
54. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol 1990;29:371-5.
55. Pasricha JS, Khaitan BK, Raman RS, Chandra M. Dexamethasone cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995;34:875-82.
56. Pasricha JS, Thanzama J, Khan UK. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol 1988;119:73-7.
57. Pasricha JS, Das SS. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris. Int J Dermatol 1992;31:875-7. (Pubitemid 23014833)
58. Kanwar AJ, Kaur S, Thami GP. Long-term efficacy of dexamethasone- cyclophosphamide pulse therapy in pemphigus. Dermatology 2002;204:228-31. (Pubitemid 34628313)
59. Kandan S, Thappa DM. Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: A case series. Indian J Dermatol Venereol Leprol 2009;75:373-8.
60. Masood Q, Hassan I, Majid I, Khan D, Manzooi S, Qayoom S, et al. Dexamethasone cyclophosphamide pulse therapy in pemphigus: Experience in Kashmir valley. Indian J Dermatol Venereol Leprol 2003;69:97-9. (Pubitemid 44057832)
61. Sacchidanand S, Hiremath NC, Natraj HV, Revathi TN, Rani S, Pradeep G, et al. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders in Victoria Hospital, Bangalore. Dermatol Onth l ine J 2003;9:2.
62. Gupta R. Prolonged remission of pemphigus induced by dexamethasone- cyclophosphamide pulse therapy. Indian J Dermatol Venereol Leprol 2007;73:121-2.
63. Manzoor S, Bhat Y, Ahmad S, Andleeb, Inam. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Indian J Dermatol Venereol Leprol 2009;75:184-6.
64. Zivanovic D, Medenica L, Tanasilovic S, Vesic S, Skiljevic D, Tomovic M. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: A review of 72 cases. Am J Clin Dermatol 2010;11:123-9.
65. Saha M, Powell AM, Bhogal B, Black MM, Groves RW. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus. Br J Dermatol 2010;162:790-7.
66. Shaik F, Botha J, Aboobaker J, Mosam A. Corticosteroid/cyclophosphamide pulse treatment in South African patients with pemphigus. Clin Exp Dermatol 2010;35:245-50.
67. Ramam M. Dexamethasone pulse therapy in Dermatology. Indian J Dermatol Venereol Leprol 2003;69:319-22. (Pubitemid 39217060)
68. Mahajan VK, Sharma NL, Sharma RC, Garg G. Twelve-year clinico-therapeutic experience in pemphigus: A retrospective study of 54 cases. Int J Dermatol 2005;44:821-7. (Pubitemid 41535697)
69. Sethy PK, Khandpur S, Sharma VK. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris. Indian J Dermatol Venereol Leprol 2009;75:476-82.
70. Pasricha JS, Poonam. Current regimen of pulse therapy for pemphigus; minor modifications, improved results. Indian J Dermatol Venereol Leprol 2008;74:217-21. (Pubitemid 351918873)
71. Ramam M. Prolonged oral antimicrobial and cyclophosphamide therapy in pemphigus: Need for caution. Indian J Dermatol Venereol Leprol 2009;75:85.
72. Pasricha JS. Pulse therapy as a cure for autoimmune diseases. Indian J Dermatol Venereol Leprol 2003;69:323-8. (Pubitemid 39217061)
73. Rao PN, Laksmi TS. Pulse therapy and its modifications in pemphigus: A 6-year study. Indian J Dermatol Venereol Leprol 2003;69:329-33. (Pubitemid 39217062)
74. Gokhale NR, Mahajan PM, Sule RR, Belgaumkar VA, Jain SM. Treatment of pemphigus with intravenous pulse cyclophosphamide. Indian J Dermatol Venereol Leprol 2003;69:334-7. (Pubitemid 39217063)
75. Beissert S, Mimouni D, Kanwar AJ, Solomons N, Kalia V, Anhalt GJ. Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: A multicenter, randomized, placebo-controlled trial. J Invest Dermatol 2010;130:2041-8.
76. Vanikar AV, Modi PR, Patel RD, Kanodia KV, Shah VR, Trivedi VB, et al. Hematopoietic stem cell transplantation in autoimmune diseases: The Ahmedabad experience. Transplant Proc 2007;39:703-8. (Pubitemid 46584717)
77. Jain R, Kumar B. Immediate and delayed complications of dexamethasone-cyclophosphamide pulse therapy. J Dermatol 2003;10:713-8. (Pubitemid 37370224)
78. Dhar S, Kanwar AJ. Facial flushing-A side effect of pulse therapy. Dermatology 1994;188:332. (Pubitemid 24105497)
79. Kanwar AJ, Kaur S, Dhar S, Ghosh S. Hiccup-A side effect of pulse therapy. Dermatology 1993;187:279. (Pubitemid 23333940)
80. Jain R, Bali H, Sharma VK, Kumar B. Cardiovascular effects of corticosteroid pulse therapy: A prospective controlled study on pemphigus patients. Int J Dermatol 2005;44:285-8. (Pubitemid 40542142)
81. Kumrah L, Ramam M, Shah P, Pandey RM, Pasricha JS. Pituitary-adrenal function following dexamethasone-cyclophosphamide pulse therapy for pemphigus. Br J Dermatol 2001; 145: 944-8. (Pubitemid 34204469)
82. Pandhi RK, Gupta LK, Girdhar M. Azathioprine-Induced drug fever. Int J Dermatol 1994;33:198. (Pubitemid 24108786)
83. Hodgson TA, Fidler SJ, Speight PM, Weber JN, Porter SR. Oral pemphigus vulgaris associated with HIV infection. J Am Acad Dermatol 2003;49:313-5. (Pubitemid 36951287)
84. Marfatia Y, Patel S, Makrandi S, Sharma P. Human immunodeficiency virus and pemphigus vulgaris-An interesting association. Indian J Dermatol Venereol Leprol 2007;73:354-5. (Pubitemid 47556604)
85. Kanwar AJ, Kaur S, Abraham A, Nanda A. Pemphigus in pregnancy. Am J Obstet Gynecol 1989;161:995-6. (Pubitemid 19266217)
86. Kanwar AJ, Thami GP. Pemphigus vulgaris and pregnancy-A reappraisal. Aust N Z J Obstet Gynaecol 1999;39:372-3.
87. Kanwar AJ, Dhar S. Pemphigus in pregnancy: Fetal risk. Int J Gynaecol Obstet 1993;42:176-7.
88. Nair PS, Moorthy PK, Yogiragan K. A study of mortality in dermatology. Indian J Dermatol Venereol Leprol 2005;71:23-5. (Pubitemid 40348228)
89. Kanwar AJ, Dhar S. Factors responsible for death in pemphigus patients. J Dermatol 1994;21:655-9. (Pubitemid 24308705)